Drug target
AMPA receptor
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (ionotropic glutamate receptor, AMPA subtype)
2 compounds in the CNS pipeline act on AMPA receptor.
Compounds targeting AMPA receptor
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| DT-101primarySmall molecule | PAM | — | Phase 2Major depressive disorder | Draig Therapeutics Ltd |
| RAP-219Small molecule | NAM | — | Phase 3Epilepsy | Rapport Therapeutics, Inc. |